Coloplast A/S (OTCMKTS:CLPBY – Get Rating) saw a significant decrease in short interest in the month of May. As of May 15th, there was short interest totalling 2,300 shares, a decrease of 87.1% from the April 30th total of 17,800 shares. Based on an average daily trading volume, of 55,300 shares, the days-to-cover ratio is […]
Coloplast A/S (OTCMKTS:CLPBF – Get Rating)’s stock price was down 1.5% during trading on Tuesday . The stock traded as low as $127.50 and last traded at $127.50. Approximately 35 shares traded hands during mid-day trading, a decline of 80% from the average daily volume of 175 shares. The stock had previously closed at $129.50. […]
JPMorgan Chase & Co. cut shares of Coloplast A/S (OTCMKTS:CLPBY – Get Rating) from a neutral rating to an underweight rating in a research note released on Friday morning, The Fly reports. Several other research analysts have also recently weighed in on CLPBY. Sanford C. Bernstein initiated coverage on shares of Coloplast A/S in a […]
11.05.2023 - H1 2022/23 Interim financial results, H1 2022/23 1 October 2022 - 31 March 2023 Coloplast delivered Q2 organic growth of 8% and 28% EBIT margin1). Reported revenue in DKK was up by 10%. Organic growth rates by business area: Ostomy Care 6%, . Seite 1